(Q45871293)

17 December 2017

title

VEGF gene therapy: stimulating angiogenesis or angioma-genesis? (English)

1 reference

17 December 2017

0 references

1 reference

Carmeliet P

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1102-1103

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/80430

exact match

0 references

cites work

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

1 reference

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

7 January 2021

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 reference

7 January 2021

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

1 reference

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

7 January 2021

VEGF gene delivery to muscle: potential role for vasculogenesis in adults

1 reference

7 January 2021

A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors

1 reference

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

7 January 2021

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

1 reference

7 January 2021

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

7 January 2021

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

1 reference

7 January 2021

Identifiers

DOI

10.1038/80430

1 reference

17 December 2017

Dimensions Publication ID

1002127399

0 references

Fatcat ID

release_s2k5csca2jcvjm4xi7jzdyo5ca

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s2k5csca2jcvjm4xi7jzdyo5ca

24 November 2022

mapped directly with Wikidata item

PubMed ID

11017137

1 reference

17 December 2017